Brexit Could Increase Pharma R&D Growth Opportunities in Ireland, an Industrial Info Market Brief
Brexit Could Increase Pharma R&D Growth Opportunities in Ireland, an Industrial Info Market Brief
Attachment: pharma
Ireland could become a pharmaceutical research and development (R&D) hub by capitalizing on the U.K's departure from the European Union, especially if there is a "no-deal Brexit."
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
